Los Angeles Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Los Angeles Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.98K	Sell	104 -5,151	-98%	-$528K	﹤0.01%	1966
2026 Q1	$574K	Sell	5,255 -3,264	-38%	-$311K	﹤0.01%	828
2025 Q4	$754K	Buy	+8,519	New	+$733K	﹤0.01%	747
2025 Q2	–	Sell	-38,008	Closed	-$3.19M	–	1409
2025 Q1	$3.19M	Buy	38,008 +4,352	+13%	+$405K	0.01%	345
2024 Q4	$3.1M	Hold	33,656	–	–	0.01%	377
2024 Q3	$3.13M	Buy	33,656 +6,320	+23%	+$548K	0.01%	373
2024 Q2	$2.25M	Buy	27,336 +4,831	+21%	+$355K	0.01%	425
2024 Q1	$1.49M	Buy	22,505 +4,960	+28%	+$306K	0.01%	567
2023 Q4	$996K	Sell	17,545 -4,290	-20%	-$225K	﹤0.01%	671
2023 Q3	$1.19M	Buy	21,835 +2,442	+13%	+$145K	0.01%	582
2023 Q2	$1.3M	Buy	+19,393	New	+$1.18M	0.01%	590
2022 Q2	–	Sell	-7,500	Closed	-$349K	–	1400
2022 Q1	$349K	Hold	7,500	–	–	﹤0.01%	1177
2021 Q4	$377K	Hold	7,500	–	–	﹤0.01%	1143
2021 Q3	$398K	Sell	7,500 -660	-8%	-$37.2K	﹤0.01%	1166
2021 Q2	$498K	Sell	8,160 -270	-3%	-$14.3K	﹤0.01%	1167
2021 Q1	$411K	Sell	8,430 -500	-6%	-$23.4K	﹤0.01%	1305
2020 Q4	$362K	Sell	8,930 -1,620	-15%	-$57.9K	﹤0.01%	1317
2020 Q3	$343K	Sell	10,550 -5,820	-36%	-$175K	﹤0.01%	1223
2020 Q2	$432K	Buy	16,370 +4,955	+43%	+$130K	﹤0.01%	1166
2020 Q1	$284K	Buy	+11,415	New	+$353K	﹤0.01%	1073

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Los Angeles Capital Management's LMAT Position: Q2 2026 in Review

Los Angeles Capital Management reduced its LeMaitre Vascular (LMAT) stake by 98% in Q2 2026, selling an estimated $528K and leaving 104 shares worth $9.98K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

Los Angeles Capital Management first reported a position in LMAT in Q1 2020 and has held it in 20 quarters since. The position peaked at $3.19M in Q1 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Los Angeles Capital Management held 104 shares of LeMaitre Vascular worth $9.98K as of Q2 2026.
Los Angeles Capital Management sold 5,151 LeMaitre Vascular shares in Q2 2026, an estimated $528K.
LeMaitre Vascular made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1966 holding.
Los Angeles Capital Management first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 20 quarters since.
Los Angeles Capital Management's LeMaitre Vascular position peaked at $3.19M in Q1 2025.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.